A double-blind, randomized, controlled pilot trial of N-acetylcysteine in veterans with posttraumatic stress disorder and substance use disorders

Journal of Clinical Psychiatry

Volumn 77, Issue 11, 2016, Pages e1439-e1446

  Back, Sudie E ^a,b   McCauley, Jenna L ^a   Korte, Kristina J ^a   Gros, Daniel F ^a,b   Leavitt, Virginia ^a,b   Gray, Kevin M ^a   Hamner, Mark B ^a   DeSantis, Stacia M ^a,b   Malcolm, Robert ^a,b   Brady, Kathleen T ^a,b   Kalivas, Peter W ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; PLACEBO;

ADULT; AGED; ARTICLE; BASAL GANGLION; CLINICAL ARTICLE; COGNITIVE BEHAVIORAL THERAPY; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG CRAVING; DRUG DEPENDENCE; DRUG EFFICACY; DRUG RETENTION; DRUG SAFETY; DRUG TOLERABILITY; FAINTNESS; FEMALE; HEART ARRHYTHMIA; HEARTBURN; HUMAN; MALE; MEDICATION COMPLIANCE; PANCREATITIS; PATIENT COMPLIANCE; PILOT STUDY; POSTTRAUMATIC STRESS DISORDER; PREFRONTAL CORTEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT RESPONSE; VETERAN; XEROSTOMIA; ALCOHOLISM; COGNITIVE THERAPY; COMBAT DISORDERS; COMORBIDITY; COMPARATIVE STUDY; CRAVING; DRUG EFFECTS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGY; STRESS DISORDERS, POST-TRAUMATIC; SUBSTANCE-RELATED DISORDERS;

ACETYLCYSTEINE; ADULT; ALCOHOLISM; COGNITIVE THERAPY; COMBAT DISORDERS; COMBINED MODALITY THERAPY; COMORBIDITY; CRAVING; DIAGNOSIS, DUAL (PSYCHIATRY); DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; STRESS DISORDERS, POST-TRAUMATIC; SUBSTANCE-RELATED DISORDERS; VETERANS;

EID: 84998678052     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.15m10239     Document Type: Article

References (42)

1. Seal KH, Metzler TJ, Gima KS, et al. Trends and risk factors for mental health diagnoses among Iraq and Afghanistan veterans using Department of Veterans Affairs health care, 2002-2008. Am J Public Health. 2009;99(9):1651-1658. PubMed doi:10.2105/AJPH.208.150284
2. Smith TC, Ryan MA, Wingard DL, et al; Millennium Cohort Study Team. New onset and persistent symptoms of post-traumatic stress disorder self reported after deployment and combat exposures: prospective population based US military cohort study. BMJ. 2008;336(7640):366-371. PubMed doi:10.136/bmj.39430.638241.AE
3. Petrakis IL, Rosenheck R, Desai R. Substance use comorbidity among veterans with posttraumatic stress disorder and other psychiatric illness. Am J Addict. 2011;20(3):185-189. PubMed doi:10.1/j.1521-0391.201.0126.x
4. Young HE, Rosen CS, Finney JW. A survey of PTSD screening and referral practices in VA addiction treatment programs. J Subst Abuse Treat. 2005;28(4):313-319. PubMed doi:10.1016/j.jsat.205.02.06
5. Hertzberg MA, Feldman ME, Beckham JC, et al. Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans. Ann Clin Psychiatry. 2000;12(2):101-105. PubMed doi:10.3109/104012309147096
6. Friedman MJ, Marmar CR, Baker DG, et al. Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. J Clin Psychiatry. 2007;68(5):711-720. PubMed doi:10.4088/JCP.v68n0508
7. Batki SL, Pennington DL, Lasher B, et al. Topiramate treatment of alcohol use disorder in veterans with posttraumatic stress disorder: a randomized controlled pilot trial. Alcohol Clin Exp Res. 2014;38(8):2169-2177. PubMed doi:10.1/acer.12496
8. Brady KT, Sonne S, Anton RF, et al. Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder. Alcohol Clin Exp Res. 2005;29(3):395-401. PubMed doi:10.1097/01.ALC.0156129.98265.57
9. Foa EB, Yusko DA, McLean CP, et al. Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial. JAMA. 2013;310(5):488-495. PubMed doi:10.101/jama.2013.8268
10. Sofuoglu M, Rosenheck R, Petrakis I. Pharmacological treatment of comorbid PTSD and substance use disorder: recent progress. Addict Behav. 2014;39(2):428-433. PubMed doi:10.1016/j.adbeh.2013.08.014
11. Dean O, Giorlando F, Berk M. N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action. J Psychiatry Neurosci. 2011;36(2):78-86. PubMed doi:10.1503/jpn.1057
12. Kalivas PW, Volkow ND. New medications for drug addiction hiding in glutamatergic neuroplasticity. Mol Psychiatry. 2011;16(10):974-986. PubMed doi:10.1038/mp.201.46
13. Grant JE, Odlaug BL, Chamberlain SR, et al. A randomized, placebo-controlled trial of N-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers. J Clin Psychiatry. 2014;75(1):39-45. PubMed doi:10.4088/JCP.13m08411
14. Baker DA, McFarland K, Lake RW, et al. Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse. Nat Neurosci. 2003;6(7):743-749. PubMed doi:10.1038/n1069
15. Norman SB, Myers US, Wilkins KC, et al. Review of biological mechanisms and pharmacological treatments of comorbid PTSD and substance use disorder. Neuropharmacology. 2012;62(2):542-551. PubMed doi:10.1016/j.neuropharm.201.04.032
16. Aupperle RL, Melrose AJ, Stein MB, et al. Executive function and PTSD: disengaging from trauma. Neuropharmacology. 2012;62(2):686-694. PubMed doi:10.1016/j.neuropharm.201.02.08
17. Bremner JD, Elzinga B, Schmahl C, et al. Structural and functional plasticity of the human brain in posttraumatic stress disorder. Prog Brain Res. 2008;167:171-186. PubMed doi:10.1016/S079-6123(07)67012-5
18. Goldstein RZ, Volkow ND. Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci. 2011;12(11):652-669. PubMed doi:10.1038/nrn319
19. Huang MX, Yurgil KA, Robb A, et al. Voxel-wise resting-state MEG source magnitude imaging study reveals neurocircuitry abnormality in active-duty service members and veterans with PTSD. Neuroimage Clin. 2014;5:408-419. PubMed doi:10.1016/j.nicl.2014.08.04
20. Pitman RK, Rasmusson AM, Koenen KC, et al. Biological studies of post-traumatic stress disorder. Nat Rev Neurosci. 2012;13(11):769-787. PubMed doi:10.1038/nrn39
21. Rauch SL, Whalen PJ, Shin LM, et al. Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder: a functional MRI study. Biol Psychiatry. 2000;47(9):769-776. PubMed doi:10.1016/S06-323(0)0828-3
22. Osuch EA, Willis MW, Bluhm R, et al; CSTS Neuroimaging Study Group. Neurophysiological responses to traumatic reminders in the acute aftermath of serious motor vehicle collisions using [15O]-H2O positron emission tomography. Biol Psychiatry. 2008;64(4):327-335. PubMed doi:10.1016/j.biopsych.208.03.010
23. Sripada RK, King AP, Garfinkel SN, et al. Altered resting-state amygdala functional connectivity in men with posttraumatic stress disorder. J Psychiatry Neurosci. 2012;37(4):241-249. PubMed doi:10.1503/jpn.1069
24. Gu H, Salmeron BJ, Ross TJ, et al. Mesocorticolimbic circuits are impaired in chronic cocaine users as demonstrated by resting-state functional connectivity. Neuroimage. 2010;53(2):593-601. PubMed doi:10.1016/j.neuroimage.2010.06.06
25. McHugh MJ, Demers CH, Salmeron BJ, et al. Cortico-amygdala coupling as a marker of early relapse risk in cocaine-addicted individuals. Front Psychiatry. 2014;5:16. PubMed doi:10.389/fpsyt.2014.016
26. Feil J, Sheppard D, Fitzgerald PB, et al. Addiction, compulsive drug seeking, and the role of frontostriatal mechanisms in regulating inhibitory control. Neurosci Biobehav Rev. 2010;35(2):248-275. PubMed doi:10.1016/j.neubiorev.2010.03.01
27. American Psychiatric Association. Diagnostic and Statistical Manual for Mental Disorders. Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
28. Folstein MF, Folstein SE, McHugh PR. "Minimental state:" a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-198. PubMed doi:10.1016/02-3956(75)9026-6
29. Carroll KM, Kosten TR, Rounsaville BJ. Choosing a behavioral therapy platform for pharmacotherapy of substance users. Drug Alcohol Depend. 2004;75(2):123-134. PubMed doi:10.1016/j.drugalcdep.204.02.07
30. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(suppl 20):22-33, quiz 34-57. PubMed
31. Blake DD, Weathers FW, Nagy LM, et al. The development of a clinician-administered PTSD scale. J Trauma Stress. 1995;8(1):75-90. PubMed doi:10.102/jts.249080106
32. Weathers FW, Huska JA, Keane T. M: PCLM for DSMIV. Boston, MA: National Center for PTSD -Behavioral Science Division; 1991.
33. Sobell LC, Sobell MB. Timeline follow-back: a technique for assessing self-reported alcohol consumption. In: Litten RZ, Allen JP, eds. Measuring Alcohol Consumption: Psychosocial and Biochemical Methods. Totowa, NJ: Humana Press; 1992:41-72. doi:10.107/978-1-4612-0357-53
34. Beck A, Steer R, Brown G. Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation; 1996.
35. Posner K, Brown GK, Stanley B, et al. The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011;168(12):1266-1277. PubMed doi:10.176/api.ajp.201.101704
36. Cohen J. Statistical Power for the Social Sciences. Hillsdale, NJ: Laurence Erlbaum and Associates; 1988.
37. Gros DF, Price M, Magruder KM, et al. Symptom overlap in posttraumatic stress disorder and major depression. Psychiatry Res. 2012;196(2-3):267-270. PubMed doi:10.1016/j.psychres.201.10.02
38. Goldstein RZ, Craig AD, Bechara A, et al. The neurocircuitry of impaired insight in drug addiction. Trends Cogn Sci. 2009;13(9):372-380. PubMed doi:10.1016/j.tics.209.06.04
39. Grant JE, Odlaug BL, Kim SW. N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a doubleblind, placebo-controlled study. Arch Gen Psychiatry. 2009;66(7):756-763. PubMed doi:10.101/archgenpsychiatry.209.60
40. Gray KM, Carpenter MJ, Baker NL, et al. A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents. Am J Psychiatry. 2012;169(8):805-812. PubMed doi:10.176/api.ajp.2012.120105
41. Asevedo E, Mendes AC, Berk M, et al. Systematic review of N-acetylcysteine in the treatment of addictions. Rev Bras Psiquiatr. 2014;36(2):168-175. PubMed doi:10.1590/1516-46-2013-124
42. Petrakis IL, Ralevski E, Desai N, et al. Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence. Neuropsychopharmacology. 2012;37(4):996-1004. PubMed doi:10.1038/np.201.283